ENTITY
Laekna

Laekna (2105 HK)

36
Analysis
Health Care • China
Laekna is a clinical-stage biotechnology company focused on the discovery, development, and commercialization of innovative therapies for cancer, metabolic diseases, and liver fibrosis. Its pipeline includes drug candidates such as LAE002 for breast and prostate cancer, LAE001 for prostate cancer, and LAE102 for obesity. The company was founded in 2016 and is headquartered in Yuyao, China.
more
Company Event • 25 Aug 2026 16:00 • Upcoming
Add To Calendar

H1 2026

Company Event • 18 Mar 2026 17:00 • Upcoming
Add To Calendar

H2 2025

Company Event • 13 Aug 2025 16:00 • Upcoming
Add To Calendar

H1 2025

Company Event • 24 Mar 2025 17:00 • Upcoming
Add To Calendar

H2 2024

Company Event • 16 Aug 2024 16:00 • Upcoming
Add To Calendar

H1 2024

x